Genetic Variants of Coagulation Factor XI Show Association with Ischemic Stroke Up to 70 Years of Age

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Hanson, Ellen ^a   Nilsson, Staffan ^b   Jood, Katarina ^a   Norrving, Bo ^c,d   Engström, Gunnar ^e   Blomstrand, Christian ^a   Lindgren, Arne ^c,d   Melander, Olle ^e   Jern, Christina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 11; CYTOSINE; GUANINE; THYMINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; FXI GENE; GENE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; AGED; FACTOR XI; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE; SWEDEN;

EID: 84884550124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075286     Document Type: Article

References (32)

1. Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, et al. (2009) Factor XI contributes to thrombin generation in the absence of factor XII. Blood 114: 452-458. doi:10.1182/blood-2009-02-203604. PubMed: 19351955.
2. Woodruff RS, Sullenger B, Becker RC, (2011) The many faces of the contact pathway and their role in thrombosis. J Thromb Thrombolysis 32: 9-20. doi:10.1007/s11239-011-0578-5. PubMed: 21404067.
3. Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer HU, et al. (2006) Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 203: 513-518. doi:10.1084/jem.20052458. PubMed: 16533887.
4. Yamashita A, Nishihira K, Kitazawa T, Yoshihashi K, Soeda T, et al. (2006) Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery. J Thromb Haemost 4: 1496-1501. doi:10.1111/j.1538-7836.2006.01973.x. PubMed: 16839345.
5. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, et al. (2011) Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost 105: 269-273. PubMed: 21057700.
6. Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U, (2008) Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 111: 4113-4117. doi:10.1182/blood-2007-10-120139. PubMed: 18268095.
7. Salomon O, Steinberg DM, Dardik R, Rosenberg N, Zivelin A, et al. (2003) Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 1: 658-661. doi:10.1046/j.1538-7836.2003.00195.x. PubMed: 12871398.
8. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR, (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342: 696-701. doi:10.1056/NEJM200003093421004. PubMed: 10706899.
9. Cushman M, O'Meara ES, Folsom AR, Heckbert SR, (2009) Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 114: 2878-2883. doi:10.1182/blood-2009-05-219915. PubMed: 19617576.
10. Siegerink B, Govers-Riemslag JW, Rosendaal FR, Ten Cate H, Algra A, (2010) Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation 122: 1854-1861. doi:10.1161/CIRCULATIONAHA.110.943738. PubMed: 20956210.
11. Suri MF, Yamagishi K, Aleksic N, Hannan PJ, Folsom AR, (2010) Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Cerebrovasc Dis 29: 497-502. doi:10.1159/000297966. PubMed: 20299790.
12. Yang DT, Flanders MM, Kim H, Rodgers GM, (2006) Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events. Am J Clin Pathol 126: 411-415. doi:10.1309/QC259F09UNMKVP0R. PubMed: 16880142.
13. Tanis B, Algra A, van der Graaf Y, Helmerhorst F, Rosendaal F, (2006) Procoagulant factors and the risk of myocardial infarction in young women. Eur J Haematol 77: 67-73. doi:10.1111/j.1600-0609.2006.00656.x. PubMed: 16608503.
14. Doggen CJ, Rosendaal FR, Meijers JC, (2006) Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 108: 4045-4051. doi:10.1182/blood-2005-12-023697. PubMed: 16931632.
15. Schumacher WA, Luettgen JM, Quan ML, Seiffert DA, (2010) Inhibition of factor XIa as a new approach to anticoagulation. Arterioscler Thromb Vasc Biol 30: 388-392. doi:10.1161/ATVBAHA.109.197178. PubMed: 20139363.
16. Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, et al. (2000) Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 67: 1452-1459. doi:10.1086/316903. PubMed: 11038326.
17. Sabater-Lleal M, Martinez-Perez A, Buil A, Folkersen L, Souto JC, et al. (2012) A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI Level and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 32: 2008-2016. doi:10.1161/ATVBAHA.112.248492. PubMed: 22701019.
18. Li Y, Bezemer ID, Rowland CM, Tong CH, Arellano AR, et al. (2009) Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 7: 1802-1808. doi:10.1111/j.1538-7836.2009.03544.x. PubMed: 19583818.
19. Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, et al. (2008) Gene variants associated with deep vein thrombosis. JAMA 299: 1306-1314. doi:10.1001/jama.299.11.1306. PubMed: 18349091.
20. Undas A, Slowik A, Gissel M, Mann KG, Butenas S, (2011) Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events. Thromb Res 128: e62-e66. doi:10.1016/j.thromres.2011.01.013. PubMed: 21820158.
21. Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C, (2005) Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke 36: 1383-1387. doi:10.1161/01.STR.0000169944.46025.09. PubMed: 15933254.
22. Olsson S, Stokowska A, Holmegaard L, Jood K, Blomstrand C, et al. (2011) Genetic variation in complement component C3 shows association with ischaemic stroke. Eur J Neurol 18: 1272-1274. doi:10.1111/j.1468-1331.2011.03377.x. PubMed: 21414106.
23. Flossmann E, Schulz UG, Rothwell PM, (2004) Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35: 212-227. PubMed: 14684773.
24. de Moerloose P, Boehlen F, (2007) Inherited thrombophilia in arterial disease: a selective review. Semin Hematol 44: 106-113. doi:10.1053/j.seminhematol.2007.01.008. PubMed: 17433903.
25. Adams HP Jr,. Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
26. Olsson S, Holmegaard L, Jood K, Sjögren M, Engström G, et al. (2012) Genetic variation within the interleukin-1 gene cluster and ischemic stroke. Stroke 43: 2278-2282. doi:10.1161/STROKEAHA.111.647446. PubMed: 22744645.
27. Hallström B, Jönsson AC, Nerbrand C, Petersen B, Norrving B, et al. (2007) Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol Scand 115: 49-54. doi:10.1111/j.1600-0404.2006.00738.x. PubMed: 17156265.
28. Li C, Engström G, Hedblad B, Berglund G, Janzon L, (2005) Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke 36: 234-238. doi:10.1161/01.STR.0000152328.66493.0a. PubMed: 15618439.
29. Westfall PH, Young SS, (1993) Resampling-based multiple testing: examples and methods for p-value adjustment. New York, NY: John Wiley & Sons.
30. Delluc A, Gourhant L, Lacut K, Mercier B, Audrezet MP, et al. (2010) Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study. Thromb Haemost 103: 1161-1169. doi:10.1160/TH09-07-0430. PubMed: 20352152.
31. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, et al. (2007) Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 297: 489-498. doi:10.1001/jama.297.5.489. PubMed: 17284699.
32. Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, et al. (2011) New gene variants associated with venous thrombosis: a replication study in White and Black Americans. J Thromb Haemost 9: 489-495. doi:10.1111/j.1538-7836.2011.04185.x. PubMed: 21232005.